MGO One Seven’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

MGO One Seven’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,482	Closed	-$851K	–	906
2022 Q4	$851K	Sell	7,482 -430	-5%	-$35.7K	0.09%	259
2022 Q3	$489	Sell	7,912 -382	-5%	-$26.7K	0.02%	391
2022 Q2	$662K	Sell	8,294 -321	-4%	-$30.4K	0.09%	253
2022 Q1	$906K	Sell	8,615 -407	-5%	-$39.7K	0.1%	229
2021 Q4	$972K	Buy	9,022 +60	+0.7%	+$6.54K	0.1%	227
2021 Q3	$1.07M	Sell	8,962 -446	-5%	-$46.3K	0.14%	188
2021 Q2	$881K	Sell	9,408 -126	-1%	-$11.6K	0.12%	205
2021 Q1	$877K	Sell	9,534 -45	-0.5%	-$3.8K	0.15%	171
2020 Q4	$701K	Sell	9,579 -230	-2%	-$17.1K	0.14%	185
2020 Q3	$762K	Sell	9,809 -416	-4%	-$28.6K	0.18%	150
2020 Q2	$568K	Buy	+10,225	New	+$437K	0.15%	191
2019 Q1	–	Sell	-12	Closed	–	–	1938
2018 Q4	$0	Buy	+12	New	+$235	﹤0.01%	1995

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MGO One Seven's HZNP Position: Q1 2023 in Review

MGO One Seven sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 7,482 shares — an estimated $851K sold.

MGO One Seven first reported a position in HZNP in Q4 2018 and held it in 12 quarters. The position peaked at $1.07M in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

MGO One Seven reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
MGO One Seven sold 7,482 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $851K.
MGO One Seven first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 12 quarters.
MGO One Seven's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.07M in Q3 2021.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on MGO One Seven's 13F filing for Q1 2023, filed 8 May 2023.